Ariosa Diagnostics, Inc. v. Illumina, Inc.

CourtCourt of Appeals for the Federal Circuit
DecidedDecember 11, 2017
Docket16-2388
StatusUnpublished

This text of Ariosa Diagnostics, Inc. v. Illumina, Inc. (Ariosa Diagnostics, Inc. v. Illumina, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Ariosa Diagnostics, Inc. v. Illumina, Inc., (Fed. Cir. 2017).

Opinion

NOTE: This disposition is nonprecedential.

United States Court of Appeals for the Federal Circuit ______________________

ARIOSA DIAGNOSTICS, INC., Appellant

v.

ILLUMINA, INC., Appellee

JOSEPH MATAL, PERFORMING THE FUNCTIONS AND DUTIES OF THE UNDER SECRETARY OF COMMERCE FOR INTELLECTUAL PROPERTY AND DIRECTOR, U.S. PATENT AND TRADEMARK OFFICE, Intervenor ______________________

2016-2388, 2017-1020 ______________________

Appeals from the United States Patent and Trade- mark Office, Patent Trial and Appeal Board in No. IPR2014-01093. ______________________

Decided: December 11, 2017 ______________________

THOMAS SAUNDERS, Wilmer Cutler Pickering Hale and Dorr LLP, Washington, DC, argued for appellant. Also represented by JOSHUA LLOYD STERN, DAVID LANGDON 2 ARIOSA DIAGNOSTICS, INC. v. ILLUMINA, INC.

CAVANAUGH, JOSHUA KOPPEL, HEATHER M. PETRUZZI; ROBERT J. GUNTHER, JR., New York, NY.

EDWARD R. REINES, Weil, Gotshal & Manges LLP, Redwood Shores, CA, argued for appellee. Also repre- sented by DEREK C. WALTER.

BENJAMIN T. HICKMAN, Office of the Solicitor, United States Patent and Trademark Office, Alexandria, VA, argued for intervenor. Also represented by NATHAN K. KELLEY, MICHAEL SUMNER FORMAN, THOMAS W. KRAUSE, SCOTT WEIDENFELLER. ______________________

Before MOORE, BRYSON, and HUGHES, Circuit Judges. MOORE, Circuit Judge. Ariosa appeals the Patent Trial and Appeal Board’s (“Board”) inter partes review decision holding claims 1–22 of U.S. Patent No. 7,955,794 were not anticipated by U.S. Patent Publication No. 2002/0172946 (“Fan”) because Fan was not prior art. Because the Board did not err in determining that Fan is not prior art and did not abuse its discretion in denying Ariosa’s request for rehearing, we affirm the Board’s decision. Because we lack jurisdiction to review the termination of the ex parte reexamination proceedings, we dismiss the appeal of the termination of those proceedings. AFFIRMED IN PART AND DISMISSED IN PART COSTS No costs.

Free access — add to your briefcase to read the full text and ask questions with AI

Cite This Page — Counsel Stack

Bluebook (online)
Ariosa Diagnostics, Inc. v. Illumina, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/ariosa-diagnostics-inc-v-illumina-inc-cafc-2017.